Drug profile · INN
ferumoxytol
FERAHEME
ferumoxytol (FERAHEME) is a unknown. Associated with Takeda. Route of administration: intravenous. Current US regulatory status: approved.
FDA: approved EMA: application withdrawn Blood and blood forming organs (B03) B03AC
US status approved
Patents linked 4
Pipeline programs 6
News articles 0
Drug details — ferumoxytol
- US status
- approved
- Class
- Blood and blood forming organs (B03)
- Route
- INTRAVENOUS
- Patents
- 4
- Programs
- 6
- Data quality
- 0.89
Quick answer
ferumoxytol (FERAHEME) is a unknown. Associated with Takeda. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN ferumoxytol
Brand FERAHEME
Mechanism Unknown
Therapeutic class Blood and blood forming organs (B03)
Route INTRAVENOUS
Formulation SOLUTION
ATC code B03AC
Originator Takeda
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | application withdrawn | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is ferumoxytol?
ferumoxytol (FERAHEME) is a unknown. Associated with Takeda. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for ferumoxytol?
FERAHEME is a marketed brand name for ferumoxytol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ferumoxytol?
ferumoxytol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.